Here is another article, from a doctor's point of view which also lays out a lot of information missing from the media hype surrounding this:
As a paediatrician, let me tell you the sad truth about whether Charlie Gard really could have ever survived'
At first glance, it could be interpreted that the inaction of GOSH resulted in Charlie’s one chance at a normal life being cruelly snatched away from him. This is clearly the view of many individuals, given the abuse and intimidation that has been directed at GOSH staff over the last few weeks.
Bear in mind however that in January, the only medical professionals in a position to fully assess Charlie and have enough information to make informed judgments on his prognosis were those at GOSH. GOSH also
asked other external, experienced paediatricians to assess him independently, including a metabolic specialist from Southampton whom Charlie’s parents had wanted to assess him.
All of these professionals agreed with the GOSH view that his underlying condition had progressed to a point where any intervention would be futile, only serving to prolong the process of dying rather than improving his quality of life.
The world of rare mitochondrial disease research is small and the experts in the world-renowned centres know each other and communicate with each other regularly.
It has been reported that GOSH approached Professor Hirano in January 2017 to explore experimental nucleoside therapy (NBT) and invited him to come to London to assess Charlie at that time. GOSH were preparing an ethics committee application to seek permission to use NBT for Charlie when he deteriorated in January.
What was the basis of such a huge divergence of opinion on Charlie’s baseline condition between GOSH and Charlie’s family and the overseas teams? Charlie’s parents have stated that they believe that there was no evidence of “irreversible brain damage” in January. Indeed, he had an MRI scan of his brain that has been described as structurally normal. A normal scan does not mean that a brain is working normally. Charlie was having severe fits that indicated that the function of his brain was compromised and, with knowledge of the natural history of his condition, GOSH recognised that he had reached a point where even with experimental treatment, the likelihood of any significant improvement in his condition was negligible.
Charlie’s parents disagreed and were supported in this by Professor Hirano who provided written statements in support of his parent’s position to be used as evidence in the various court hearings. After the courts’ rulings in favour of GOSH, Hirano then stated that he had new evidence that had not been considered previously which led to the recent return to court.
During this process, it transpired that Hirano had never physically assessed Charlie nor had he had sight of his medical records and investigations, including the second opinions of doctors from outside GOSH. It was also revealed that potentially he stood to gain financially from the use of NBT. His evidence flagged up potential hope for the future treatment of mitochondrial diseases but there was nothing to suggest that it could help Charlie following reassessment of his condition.
.....